Updates matching "Access to Biomarker Testing"

NASHVILLE, Tenn. – On Tuesday, April 7, Senate Bill 0435 to expand coverage of biomarker testing in Tennessee overcame a significant hurdle, passing the Senate Commerce and Labor Committee. SB0435 would expand coverage of biomarker testing for patients enrolled in state employee health insurance plans and TennCare.

NASHVILLE, Tenn. – On Monday, March 30, the Tennessee House unanimously passed House Bill 0484 that would expand coverage of biomarker testing for patients facing a variety of diseases including cancer. “ACS CAN applauds the passage of HB0484 in the House and appreciates the bipartisan support. We

Cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine through biomarker testing.

Dozens of volunteer advocates, including cancer survivors, patients, and caregivers from across Hawai’i united at the state capitol Tuesday for ‘Cancer Action Day’ to urge lawmakers to support several policies to aid in the fight against cancer including a bill that would increase access to colorectal cancer screenings for residents.

Earlier today, a coalition of patient advocates, legislative champions, public health leaders and concerned cancer survivors, led by the American Cancer Society Cancer Action Network (ACS CAN), came together to applaud the Senate and call on Governor Hochul and Assembly leadership to join the Senate in preserving Medicaid enrollees’ access to biomarker testing.

JACKSON, Miss. – Cancer advocates are celebrating after Gov. Tate Reeves signed “Jill’s Law” House Bill 565 Monday night, paving the way for increased access to biomarker testing for Mississippians with state-regulated health insurance plans. Biomarker testing is a key tool used by physicians to identify the

Earlier today, cancer survivors, medical professionals and patient advocates from across Delaware convened in Dover at Legislative Hall as a part of ‘Delaware Advocacy Day.’ The main focus of Advocacy Day, which was hosted by the American Cancer Society Cancer Action Network (ACS CAN) and the Alzheimer’s Association (ALZ), was for volunteers to connect directly with legislators and ask for their support of Senate Bill 120, a bipartisan proposal to improve Delawareans’ access to biomarker testing.

The one-house budget proposals revealed a clear divide in the Legislature’s approach to the equitable treatment of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer Action Network (ACS CAN). The Assembly took a more mixed approach accepting parts of the Governor’s proposed language while rejecting others.

JACKSON, Miss. – The Mississippi Senate passed “Jill’s Law” House Bill 565 Wednesday, paving the way for increased access to biomarker testing for Mississippians with state-regulated health insurance plans. Biomarker testing is a key tool used by physicians to identify the most effective treatments for cancer and